NCT05774197 2025-11-04
STAMP+CBT
University of Oklahoma
Phase NA Completed
Clinical Trials
26 trialsNCT05442866 2025-05-25
Virtual Reality for Outpatient Cancer Pain Management
Medstar Health Research Institute
Phase NA Completed
NCT05366413 2025-04-16
Early Interventional Treatment for Cancer Pain
Dana-Farber Cancer Institute
Phase NA Completed
NCT05328973 2024-12-02
Intraoperative Aromatherapy Versus Placebo for Port-a-Cath Placement Under Monitored Anesthesia Care. A Randomized Controlled Trial
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01337089 2023-04-12
Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Jazz Pharmaceuticals
Phase 3 Completed
NCT01361607 2023-04-12
SPRAY III
Jazz Pharmaceuticals
Phase 3 Completed
NCT01424566 2023-04-12
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
Jazz Pharmaceuticals
Phase 3 Completed
NCT02609828 2023-02-16
Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy
Pfizer
Phase 3 Completed
NCT03146806 2021-09-09
Intranasal (NAS) Ketamine for Cancer Pain
Emory University
Phase 1/2 Completed
NCT03031938 2021-06-25
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
Pfizer
Phase 3 Completed
NCT00830180 2021-04-05
Open Label Extension In Cancer Patients
Pfizer
Phase 2 Completed
NCT02366611 2021-01-22
Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cancer
University of Michigan
Phase NA Completed
NCT03204942 2020-07-07
Dorsal Root Ganglion Thermal Radiofrequency Versus Pulsed Radiofrequency for Metastatic Pain in Thoracic Vertebral Body
National Cancer Institute, Egypt
Phase NA Completed
NCT03727373 2020-03-27
QualiPain
University Hospital Schleswig-Holstein
Completed
NCT00656305 2020-02-05
ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain
InSightec
Phase NA Completed
NCT00472303 2019-11-04
A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Completed
NCT01384877 2019-07-12
Subcutaneous Lidocaine For Cancer-Related Pain
British Columbia Cancer Agency
Phase 2/3 Completed
NCT02660229 2018-11-19
SWITCH
Mundipharma Korea Ltd
Phase 4 Completed
NCT01675622 2018-05-21
Immediate-Release Oxycodone Capsules Study in Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT01313780 2017-12-22
TOP
Mundipharma Korea Ltd
Phase 4 Completed
NCT02765269 2016-12-05
Intelligent Pain Management System for Assessing Pain in Cancer Patients
Xinhua Translational Institute for Cancer Pain, Shanghai
Phase NA Completed
NCT01719757 2016-08-19
PROBE
Mundipharma Korea Ltd
Phase 4 Completed
NCT00708019 2016-05-05
Improving Cancer Pain Management Through Self-Care
University of California, San Francisco
Phase NA Completed
NCT01809106 2015-12-24
CERP
Mario Negri Institute for Pharmacological Research
Phase 4 Completed
NCT01060124 2014-04-29
An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics
Janssen Korea, Ltd., Korea
Phase 4 Completed
NCT01309386 2013-03-13
A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants
Janssen Pharmaceutical K.K.
Phase 3 Completed